LANOXIN

NDC 70515-260 · Covis Pharma US, Inc

Generic namedigoxin

Dosage formINJECTION, SOLUTION

RouteINTRAMUSCULAR, INTRAVENOUS

Active ingredient(s)DIGOXIN

Strength250 ug/mL

Pharmacologic classCardiac Glycoside [EPC], Cardiac Glycosides [CS]

Marketing categoryNDA

Packages

J1160 — Injection, digoxin, up to 0.5 mg Medicare Part B payment limit (ASP + 6%): $3.91

FDA lists these products with the same active ingredient.

59651-437 — Digoxin, 59651-438 — Digoxin, 60429-100 — Digoxin, 60687-858 — Digoxin, 60687-869 — Digoxin, 66689-327 — Digoxin, 67046-1317 — Digoxin, 69238-1991 — Digoxin, 69238-1992 — Digoxin, 69292-605 — Digoxin, 70515-261 — digoxin, 70515-262 — digoxin, 70515-263 — digoxin, 70518-3859 — Digoxin, 70518-3860 — Digoxin, 70954-200 — Digoxin, 70954-201 — Digoxin, 70954-202 — Digoxin, 71335-2463 — Digoxin, 71335-2464 — Digoxin, +39 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.